Jimmy Smedley

Jimmy Smedley, Ph.D. is the COO of Altis Biosystems. Prior to joining Altis, Jimmy served in various roles at KBI Biopharma. In his tenure at KBI, he built and grew the company’s Analytical Development department from 8 to over 65 employees. Additionally, he helped develop and lead a limited cell-based assay function into a full-service, 10-person GMP laboratory, including supporting over 25 cell lines and biological potency test methods. He received a Ph.D. in Molecular Virology & Microbiology at the University of Pittsburgh School of Medicine, and an M.S., in Biology from Duquesne University.